Biomarkers Predicting Response of Breast Cancer to Immunotherapy

    公开(公告)号:US20240336975A1

    公开(公告)日:2024-10-10

    申请号:US18579415

    申请日:2022-07-13

    CPC classification number: C12Q1/6886 C12Q2600/106 C12Q2600/158

    Abstract: The invention relates to methods of breast tumor analysis relying on the detection of expression levels of specific genes. Such methods find application in, amongst other, predicting the response of a breast cancer patient to immunotherapy or to immunogenic therapy, and in following up such responses. The expression levels of the genes can thus be used in determining which breast cancer patients are most likely to respond to immunotherapy or immunogenic therapy. The genes serving as biomarkers are individually highly performant in predicting the response of a breast tumor to immunotherapy or to immunogenic therapy, but are weak in predicting the response of melanoma to immunotherapy or to immunogenic therapy. Diagnostic kits are likewise part of the invention.

Patent Agency Ranking